The 28th Annual Meeting of the Korean College of Helicobacter and Upper Gastrointestinal Research & the 3rd Seoul International Symposium on Helicobacter and Upper Gastrointestinal Disease (SI-HUG 2020) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-17±³À°ÀÏÀÚ : 2020-07-17
±³À°Àå¼Ò : ¿ÀÇÁ¶óÀÎ & ¿Â¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: ¼¿ï ÄÜ·¡µå È£ÅÚ ±×·£µåº¼·ë2,3)
±³À°ÁÖÁ¦ :
The 28th Annual Meeting of the Korean College of Helicobacter and Upper Gastrointestinal Research & the 3rd Seoul International Symposium on Helicobacter and Upper Gastrointestinal Disease (SI-HUG 2020) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) ÁÖÃÖ±â°ü : ´ëÇÑ»óºÎÀ§Àå°ü¡¤Ç︮ÄÚ¹ÚÅÍÇÐȸ
´ã´çÀÚ : ±èÁö¿µ
¿¬¶ôó : 02-565-9946
À̸ÞÀÏ :
hpylori@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, º´¸®°ú, °¡Á¤ÀÇÇаúÀÇ»çÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇÇб³À°, ÀÇ·á¹ý
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 180,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø: 120,000, ºñȸ¿ø: 150,000, Àü°øÀÇ/°£È£»ç/Çлý: 20,000, ÇöÀåµî·Ï ȸ¿ø: 150,000¿ø, ºñȸ¿ø: 180,000¿ø, Àü°øÀÇ/°£È£»ç/Çлý: 30,000 ¿Â¶óÀÎ µî·Ïºñ: ¹ÌÁ¤
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-17 Grand Ballroom2,3 09:00~09:20 Prolonging treatment duration vs. adding bismuth: Role of bismuth in eradication Sun-Young Lee(Konkuk University Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 09:20~09:40 High dose PPI vs. P-CAB: Role of acid inhibition in eradication Takahisa Furuta(Hamamatsu University Japan)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 09:40~10:00 Culture-based vs. empirical salvage therapy for eradication Jyh-Ming Liou(National Taiwan University Taiwan)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 10:00~10:20 Antibiotics vs. probiotics for eradication: Impact of eradication on gut microbiota Nayoung Kim(Seoul National University Korea)
ÈÞ½Ä 07-17 Grand Ballroom2,3 10:20~10:40 Break ()
±³À°½Ã°£ 07-17 Grand Ballroom2,3 10:40~10:55 New insights on management of dyspepsia, gastric ulcer and gastritis Ratha-Korn Vilaichone(Thammasat University Thailand)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 10:55~11:10 Rebamipide and small bowel bleeding Than Than Aye(University of Medicine 2 Yangon Myanmar)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 11:10~11:25 Treatment of H. pylori resistant patient Miguel Edgardo M. Fores(Makati Medical Center Philippines)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 11:25~11:40 Follow-up testing after treatment of H. pylori infection Chan Gyoo Kim(National Cancer Center Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 11:40~12:20 Publishing in gastroenterology: An editor¡¯s perspective Yong Chan Lee(Yonsei University Korea)
½Ä»ç 07-17 Grand Ballroom2,3 12:20~13:20 General Assembly ()
½Ä»ç 07-17 Grand Ballroom2,3 12:20~13:20 Luncheon Symposium 1_Therapeutic advance in acid-related disease: The present and the future Kee Don Choi(University of Ulsan Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 13:20~13:30 H. pylori infection and malignant diseases in Thailand Varocha Mahachai(Chulalongkorn University and King Chulalongkorn Memorial Hospital Thailand)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 13:30~13:40 H. pylori infection and malignant diseases in Myanmar Than Than Aye(University of Medicine 2 Yangon Myanmar)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 13:40~13:50 H. pylori infection and malignant diseases in Philippines Ruter Maralit(University of the Philippines Philippines)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 13:50~14:00 H. pylori infection and malignant diseases in Vietnam Vu Van Khien(108 Central Hospital Vietnam)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 14:00~14:10 H. pylori infection and malignant diseases in Malaysia Alex Hwong Ruey Leow(Pantai Hospital Kulala Lumpur Malaysia)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 14:10~14:28 H. pylori infection and malignant diseases in Mongolia Sarantuya Gidaagaya(Intermed Hospital Mongolia)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 14:28~14:30 H. pylori infection and malignant diseases in Singapore Tiing Leong Ang(Changi General Hospital Singapore)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 14:30~14:40 H. pylori infection and malignant diseases in Indonesia Marcellus Simadibrata(Universitas Indonesia Indonesia)
Åä·Ð 07-17 Grand Ballroom2,3 14:40~15:00 Discussion ()
ÈÞ½Ä 07-17 Grand Ballroom2,3 15:00~15:20 Break ()
±³À°½Ã°£ 07-17 Grand Ballroom2,3 15:20~15:35 Effect of Helicobacter pylori reinfection on metachronous cancer risk after endoscopic submucosal dissection for early gastric cancer Jae Ok Park(National Cancer Center Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 15:35~15:50 Isolation of Helicobacter pylori using leftover tissue from rapid urease test kit Eun Jeong Gong(University of Ulsan Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 15:50~16:05 HERES (highly expressed lncRNA in esophageal squamous cell carcinoma) Epigenetically Regulates WNT-signal pathway in Esophageal Squamous Cell Carcinoma Sang Kil Lee(Yonsei University Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 16:05~16:20 Results from the pilot study of the multicentre randomised trial of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (the GISTAR Pilot study) Jin Young Park(International Agency for Research on Cancer France)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 16:20~16:40 Transcriptome based molecular subtyping for precision medicine in gastric cancer Jae-Ho Cheong(Yonsei University Korea)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 16:40~17:00 Epigenetic risk prediction of gastric cancer Toshikazu Ushijima(National Cancer Center Japan)
±³À°½Ã°£ 07-17 Grand Ballroom2,3 17:00~17:20 Genetic predisposition and alterations Hark Kyun Kim(National Cancer Center Korea)